SFRC9 can inhibit ferroptosis in colorectal cancer (CRC) by binding to GPX4 mRNA, and another study suggests that inhibiting SFRC9 in CRC may have therapeutic implications (Wang et al., 2021b). This evidence concerns the gene GPX4 and colorectal carcinoma.